Home / Services / By Technology / Protein Engineering Services / Protein Expression and Purification Service / Protein expression in mammalian cells / Custom HEK Cell Protein Expression Service
Trusted by Leading Research & Gene Therapy Developers

HEK293 Cell Expression Services

Accelerate your research with our versatile HEK293 expression platform. Ideal for rapid protein production, viral vector manufacturing, and structural biology studies. We offer both transient transfection and stable cell line development with optimized protocols for high yield and quality.

Fast Turnaround
High Transfection Efficiency
Viral Vector Ready
Learn More

Trusted by leading research and pharmaceutical institutions

Yale
Moderna
Berkeley
BioNTech
Princeton
Regeneron

Why Choose Us

High-efficiency transient transfection
Suspension-adapted cell lines available
Scalable from 1mL to 100L
Fast expression in 3-7 days

Rapid Production

From gene to purified protein in as little as 2 weeks

Mammalian PTMs

Proper folding, glycosylation, and disulfide bonds

Viral Vector Capable

AAV, lentivirus, and adenovirus production

Transfection
>90%
Service Overview

Versatile HEK293 Expression Platform

Our HEK293 expression services provide flexible solutions for rapid protein production, viral vector manufacturing, and research applications.

Transient Expression

Rapid protein production using high-efficiency transient transfection. Perfect for quick turnaround projects, protein screening, and early research stages with expression typically achieved within 3-7 days.

  • Fast expression in 3-7 days
  • Ideal for protein screening
  • Flexible scale from 1mL to 100L

Stable Cell Lines

Development of stable HEK293 cell pools or clones for consistent, long-term protein production. Suitable for structural biology, antibody characterization, and larger-scale production needs.

  • Consistent expression over passages
  • Higher overall productivity
  • Long-term production capability

Mammalian PTMs

Proper protein folding, N-linked glycosylation, disulfide bonds, and phosphorylation for functional proteins.

Suspension Culture

Adaptable suspension cell lines for scalable production in shake flasks and bioreactors without attachment requirements.

Viral Vector Ready

Validated platform for AAV, lentivirus, and adenovirus vector production for gene therapy applications.

Ready to Produce Your Recombinant Protein?

Get a customized quote for your HEK293 expression project.

Technology Platform

Advanced Expression Technologies

Our optimized HEK293 expression system delivers superior results for diverse applications.

High-Efficiency Transfection

Proprietary transfection reagents and protocols achieving >90% transfection efficiency with minimal toxicity for optimal protein yield.

PEI Pro>90% Efficiency

HEK293 Variants

Multiple HEK293 derivatives including HEK293T, HEK293F, HEK293E, and GnTI-deficient lines for specific expression requirements.

293T293FGnTI-

Scalable Platform

Suspension-adapted cells enabling seamless scale-up from milliliter shake flasks to 100L bioreactors with consistent performance.

1mL-100LSuspension

Quality Control

SDS-PAGEExpression verification
Western BlotSpecificity confirmation
Mass SpecIdentity confirmation
SEC-HPLCPurity analysis

Purification Options

His-tagNi-NTA affinity purification
FLAG-tagAnti-FLAG affinity purification
MBP/GSTFusion tag purification
Size ExclusionFinal polishing
Specifications

Flexible Options for Diverse Needs

Comprehensive specifications to meet your research and production requirements.

ParameterTransient ExpressionStable PoolStable Clone
Expression Timeline2-3 weeks4-6 weeks8-12 weeks
Scale Range1mL - 100L1L - 100L1L - 100L
Typical Yield1-50 mg/L100-500 mg/LUp to 1 g/L
ConsistencyBatch-to-batch variationHigh consistencyVery high consistency
Best ForScreening, rapid needsMedium-scale productionLarge-scale, long-term
PurificationAffinity + buffer exchangeMulti-step availableFull characterization
Workflow

Streamlined Process from Gene to Protein

Our proven workflow ensures quality and efficiency at every stage.

1

Vector Prep

Plasmid preparation and QC

2

Cell Culture

HEK293 cell expansion

3

Transfection

High-efficiency transfection

4

Expression

Protein expression and harvest

5

Purification

Purification and QC release

Applications

Diverse Applications Across Biotechnology

Our HEK293 expression services support research and development in multiple fields.

Structural Biology

HEK293 cells produce mammalian proteins with proper folding and post-translational modifications essential for structural studies by cryo-EM, X-ray crystallography, and NMR.

  • Proper disulfide bond formation
  • Authentic N-linked glycosylation
  • Membrane protein production
  • GnTI- cells for homogeneous glycans
2-3
Weeks to purified protein

Antibody Production

Rapid production of monoclonal antibodies, Fc-fusion proteins, and antibody fragments for research, preclinical studies, and screening applications.

  • Full-length IgG production
  • Fc-fusion protein constructs
  • Bispecific antibody formats
  • Antibody fragment production
50+
mg per liter typical yield

Gene Therapy Vectors

Validated platform for viral vector production including AAV, lentivirus, and adenovirus for gene therapy and cell therapy applications.

  • AAV vector production
  • Lentiviral vector manufacturing
  • Adenoviral vector production
  • GMP-grade production available
100L
Maximum production scale
Testimonials

What Our Clients Say

Trusted by researchers worldwide for quality and reliability.

"The transient expression service was exactly what we needed for our structural biology project. We received high-quality protein in just 2 weeks. The team was very responsive and accommodating with our timeline."

C
Postdoctoral Researcher
University Research Lab

"We used the stable cell line development service for our antibody characterization program. The cell pool they developed showed excellent productivity and stability. Highly recommend for antibody discovery projects."

L
Senior Scientist
Biotech Company

"Professional service with excellent communication. The AAV production was high quality and worked perfectly in our gene therapy experiments. A reliable partner for our viral vector needs."

A
Research Director
Gene Therapy Startup
Scientific Literature

Scientific Foundation

Our platform is backed by peer-reviewed research.

45 Citations

A concise guide to choosing suitable gene expression systems for recombinant protein production

Schütz A, et al. STAR Protoc. 2023.

Comprehensive decision guide comparing expression systems including HEK293, with emphasis on transient transfection advantages and high transfection efficiency.

View DOI
28 Citations

Exploring Parametric and Mechanistic Differences between Expi293F and ExpiCHO-S Cells for Transient Antibody Production Optimization

Zhou J, et al. Antibodies. 2023.

Systematic comparison of Expi293F and ExpiCHO-S cells for transient antibody production, highlighting Expi293F excellence for kappa and lambda light chain antibodies.

View DOI
32 Citations

Protein production from HEK293 cell line-derived stable pools with high protein quality and quantity to support discovery research

Sun H, et al. PLOS ONE. 2023.

Development of robust methods for HEK293-derived stable pools producing proteins with fewer cleavage fragments and higher yields than transient transfection.

View DOI
38 Citations

Augmenting recombinant antibody production in HEK293E cells: optimizing transfection and culture parameters

Heng ZSL, et al. Antib Ther. 2022.

Systematic optimization of HEK293E transfection and culture parameters achieving 452% increase in kappa chain and 252% increase in full antibody production.

View DOI
22 Citations

Comparison of vector elements and process conditions in transient and stable suspension HEK293 platforms using SARS-CoV-2 receptor binding domain as a model protein

Green EA, et al. BMC Biotechnology. 2023.

Comprehensive comparison of HEK293 transient versus stable platforms, showing stable batch culture produces 2.1x more protein with stable clone yields up to 140 mg/L.

View DOI
FAQ

Frequently Asked Questions

Find answers to common questions about our service.

HEK293 is ideal for rapid protein production, early-stage research, structural biology, and viral vector manufacturing due to fast turnaround (2-3 weeks) and high transfection efficiency. CHO cells are preferred for large-scale therapeutic protein production requiring optimized glycosylation profiles and established regulatory pathways. The choice depends on your timeline, scale, and quality requirements.
We offer multiple HEK293 derivatives: HEK293T (for viral vector production), HEK293F (suspension-adapted for scalable production), HEK293E (for stable expression), and HEK293 GnTI- (producing homogeneous N-glycans for structural biology). Each variant has specific advantages depending on your application requirements.
For transient expression, purified protein can be delivered in 2-3 weeks from gene receipt. Stable pool development takes 4-6 weeks, and stable clone development requires 8-12 weeks. Expedited services are available for urgent projects. The exact timeline depends on expression complexity and purification requirements.
Yes, we offer validated viral vector production services using HEK293 cells including AAV vectors, lentiviral vectors, and adenoviral vectors. Our platform supports both research-grade and GMP-grade production depending on your requirements. HEK293T cells are particularly well-suited for viral vector manufacturing.
We offer scalable production from 1mL (96-well format for screening) through 100L bioreactors. Suspension-adapted HEK293F cells enable seamless scale-up for larger production runs. Scale selection depends on your protein quantity needs and expression characteristics.
We offer multiple purification tags including His-tag (Ni-NTA affinity purification), FLAG-tag (Anti-FLAG affinity purification), MBP, GST, and Strep-tag. Tag selection depends on your protein characteristics and downstream applications. Untagged purification via size exclusion chromatography is also available for proteins that require tag removal.
For challenging proteins, we offer co-expression with chaperone plasmids, use of protease-deficient cell lines, and optimized culture conditions. We also provide codon optimization services and can test multiple expression strategies including different tags and signal peptides to maximize your chances of success.
Every project includes comprehensive documentation including SDS-PAGE analysis, Western blot verification, mass spectrometry identity confirmation, and SEC-HPLC purity assessment. Certificate of Analysis with all QC data is provided with each shipment. Additional characterization such as endotoxin testing and aggregation analysis is available upon request.
Yes, we maintain strict confidentiality for all customer projects. We operate under non-disclosure agreements and have robust data security protocols. Sequences are encrypted and stored securely. We do not use customer sequences for internal research or share them with third parties without explicit permission.
Yes, we provide codon optimization services to enhance expression levels in HEK293 cells. Our algorithms optimize codon usage, mRNA stability, and GC content while avoiding sequences that could cause issues. We can also incorporate patient-preferred codons for therapeutic protein development. Optimization typically improves expression by 2-10 fold depending on the original sequence.
Standard preparations typically have endotoxin levels below 10 EU/mg for research-grade proteins. For applications requiring lower endotoxin levels such as cell therapy or in vivo studies, we offer endotoxin removal services achieving levels below 1 EU/mg. We use LAL testing for accurate endotoxin quantification and can provide certificates of analysis with endotoxin data.

Ready to Start Your Project?

Get a customized quote for your Custom HEK Cell Protein Expression Service project. Our experts will respond within 24 hours.

No obligation
24h response
Expert consultation